Daré Bioscience Dividends and Buybacks
Dividend criteria checks 0/6
Daré Bioscience does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-4.1%
Buyback Yield
Total Shareholder Yield | -4.1% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate
Nov 07We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully
Jul 21Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?
Mar 12Daré rises on positive data from early-to-mid-stage trial of intravaginal ring to treat menopause symptoms
Oct 17Daré Bioscience rises as company submits application to begin trial of non-hormonal contraceptive
Oct 10Dare Bioscience reports positive progress for cream for female sexual arousal disorder
Aug 29Daré Bioscience signs agreement with Organon for bacterial vaginosis therapy
Jun 30Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?
Apr 02Diving Back Into Daré Bioscience Again
Jan 07We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully
Nov 26Daré Bioscience's DARE-BV1 shows positive action in late-stage bacterial vaginosis study
Apr 26Diving Into Daré Bioscience
Jan 31Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching
Dec 22Dare Bioscience EPS misses by $0.06
Nov 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if DARE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DARE's dividend payments have been increasing.
Dividend Yield vs Market
Daré Bioscience Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (DARE) | n/a |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.2% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast (DARE) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate DARE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DARE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate DARE's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as DARE has not reported any payouts.